key: cord-0691758-tpaub63h
authors: Parrish, James M.; Soni, Manasi; Mittal, Rahul
title: Subversion of host immune responses by otopathogens during otitis media
date: 2019-05-10
journal: J Leukoc Biol
DOI: 10.1002/jlb.4ru0119-003r
sha: 645680322382d4f5ec69710628fae33b580d50aa
doc_id: 691758
cord_uid: tpaub63h

Otitis media (OM) is one of the most common ear diseases affecting humans. Children are at greater risk and suffer most frequently from OM, which can cause serious deterioration in the quality of life. OM is generally classified into two main types: acute and chronic OM (AOM and COM). AOM is characterized by tympanic membrane swelling or otorrhea and is accompanied by signs or symptoms of ear infection. In COM, there is a tympanic membrane perforation and purulent discharge. The most common pathogens that cause AOM are Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis whereas Pseudomonas aeruginosa and Staphylococcus aureus are commonly associated with COM. Innate and adaptive immune responses provide protection against OM. However, pathogens employ a wide arsenal of weapons to evade potent immune responses and these mechanisms likely contribute to AOM and COM. Immunologic evasion is multifactorial, and involves damage to host mucociliary tract, genetic polymorphisms within otopathogens, the number and variety of different otopathogens in the nasopharynx as well as the interaction between the host's innate and adaptive immune responses. Otopathogens utilize host mucin production, phase variation, biofilm production, glycans, as well as neutrophil and eosinophilic extracellular traps to induce OM. The objective of this review article is to discuss our current understanding about the mechanisms through which otopathogens escape host immunity to induce OM. A better knowledge about the molecular mechanisms leading to subversion of host immune responses will provide novel clues to develop effective treatment modalities for OM.

Otitis media (OM) is a serious healthcare problem in both developed and developing countries. OM refers to the inflammation of the area behind the tympanic membrane called the middle ear (Fig. 1A) . The inflammatory mediators generated during OM can penetrate from middle to inner ear potentially leading to hearing loss (Fig. 1A) . OMmediated hearing loss can have serious consequences especially during childhood, including delayed language development and impaired communication. OM accounts for more than 25 million visits to physician's Abbreviations: AMPs, antimicrobial peptides; AOM, acute otitis media; CSOM, chronic suppurative otitis media; COM, chronic otitis media; ETs, eosinophilic extracellular traps (ETs); HBDs, human -defensins; LOS, lipooligosacharide; LPS, lipopolysaccharide; NETs, neutrophil extracellular traps; OM, otitis media; PAMPs, pathogen-associated molecular patterns; TNF-, tumor necrosis factor alpha. offices and is associated with significant healthcare costs. OM can be broadly classified into acute and chronic types. Acute otitis media (AOM) refers to any type of swelling of the tympanic membrane or otorrhea that is not attributable to otitis externa (Fig. 1B) . Typically, the presentation includes inflammation of the middle ear or symptoms of infection (Fig. 1B) . 1 The most common pathogens associated with AOM include Streptococcus pneumoniae, nontypeable Haemophilus influenzae (NTHi), and Moraxella catarrhalis. [2] [3] [4] [5] [6] In some cases, despite antimicrobial therapy, AOM progresses to chronic OM (COM). The most frequent type of COM is chronic suppurative OM (CSOM), characterized by tympanic membrane perforation and purulent discharge (Fig. 1B) .

Host immune responses can play a crucial role in providing protection against infections including OM. Broadly, the two general types of immune defense mechanisms are innate and adaptive immune Penetration of tympanic membrane F I G U R E 1 Schematic representation of human ear, different types of otitis media (OM), and mucin production. A) The ear is composed of three main sections: outer, middle and inner. OM refers to inflammation and/or infection of the middle ear composed of stapes, incus, and malleus as well as lined by mucosal epithelium. B) OM presentation: 1) Under normal physiologic conditions, the middle ear is clear without effusion and intact tympanic membrane; 2) However, there exists mucoid effusion and inflammation of Eustachian tube during acute OM (AOM); 3) In chronic suppurative OM (CSOM), there is perforation of tympanic membrane and purulent discharge (adapted from Bhutta et al., [148] ). C) The middle ear is lined with ciliated and secretory cells, covered with a thin layer of mucus (adapted from Bhutta et al., [148] ) responses. Each are composed of unique but interrelated cellular and secretory components. In addition, mechanical, chemical, and microbiologic barriers, including mucin production in the middle ear ( Fig.   1C ), provide protection against invading pathogens. If an otopathogen manages to cross the epithelial barrier, it is then subject to recognition by neutrophils and macrophages. At times, however, the innate immune system may not be able to clear otopathogens and hence it may require lymphocytes and the adaptive immune system to halt invasion. The lymphocytes of the adaptive immune system give a more versatile defense that can provide lasting protection against subsequent reinfection from the same pathogen. The aim of this review article is to summarize the immune responses present in the middle ear and how otopathogens evade these responses to induce OM.

The Eustachian tube epithelium is versatile in its function as a mechanical, chemical, and microbiologic barrier to infection. Beyond the epithelium's basic function as a physical barrier by virtue of tight junctions, epithelial cells combine the mechanical action of mucociliary transport with the production of other chemical barriers. Some epithelial cells function to produce lysozyme, and this combines with mucoid and serous mucus from adjacent goblet cells. This mixture is antimicrobial in nature and prevents epithelial cell invasion by otopathogens.

The mucociliary transport apparatus traps glycoproteins and mucus, ultimately propelling the fluid downward through the Eustachian tube and into the nasopharynx. Other innate defense mechanisms that prevent bacterial and viral pathogenicity on the epithelial surface can be described in terms of their secretory and nonsecretory nature. Importantly, secretory cells create mucins, lactotransferrin, lysozyme, defensins, and surfactants. These secretions foster a balanced, clean environment in the middle ear through both chemical and microbiologic mechanisms of action. [7] [8] [9] Hence, both flow and antimicrobial proteins provide protection against potential invasive otopathogens. 10 The middle ear also maintains inherently protective constituents including defensins, SPLUNC1, mucin, lysozymes, and TLRs. 9

Defensins are members of a subset of antimicrobial peptides (AMPs).

Defensins within the middle ear play a crucial role in nonenzymatic inhibition of bacteria, fungi, protozoa, and viruses. 11 Additional associations of defensins include the inhibition of bacterial toxins, proinflammatory activity that stimulates cytokine and chemokine production, as well as the creation of pores on the membranes of pathogens. 11 Three different types of defensins have been discovered, including -, -, and -defensins. Humans only express -and -defensins. 11 -Defensins are expressed in granulocytes and intestinal Paneth cells. 12 When first discovered, -defensins were named after the for-mer function, that is, human neutrophil peptide (HNP 16 Indeed, the presence of such bacteria within the middle ear is a primary source of HBD2 up-regulation.

Increased levels of HBD2 have also been associated with the increased production of cytokines. 17, 18 NTHi can trigger the up-regulation of IL-1 that can act synergistically with bacteria to enhance the expression of HBD2 in middle ear epithelial cells through the p38 MAP kinase pathway. 18 The increased expression of HBD-2, both at the mRNA and protein levels, has been demonstrated in inflamed middle ear mucosa from OM patients in comparison to that obtained from normal subjects. 19 In addition, the proinflammatory cytokine, IL-1 , upregulates HBD-2 transcription via the activation of an Src-dependent Raf-MEK1/2-ERK signaling pathway in human middle ear epithelial cell line. 19 HBD2 has also shown to be up-regulated by other proinflammatory mediators such TNF-, and LPS. 19 Finally, the recombinant human -defensin 3 (rhBD-3) has been observed as an integral part in NTHi eradication that can be compromised through biofilm formation within the middle ear. 20

In addition to the defensins, surfactant proteins have been found to halt infection, albeit by different mechanisms. Some of these functions include opsonization, aggregation, and phagocytosis. One of the surfactant proteins is SPLUNC1, which is a constituent of liquid covering middle ear mucosal surfaces that delivers both mechanical and antimicrobial effects against invading pathogens. 21 SPLUNC1 demonstrates broad-spectrum antimicrobial activity, while also preventing biofilm formation by organisms such as P. aeruginosa. 22 Similarly, mucins aid in the propagation of mucus cells, which creates a protective barrier. However, overproduction of mucin can result in delayed clearance of OM pathogens, which underscores the importance of homeostasis of the middle ear. 25 Lysozymes have a slightly different defensive role. Their primary function is to destroy the bacteria's peptidoglycan cell wall. 26 Lysozymes, target bacteria by cleaving peptidoglycans at their polysaccharide backbone.

As an essential piece of the bacterial cell well, glycans are frequently targeted by the host immune system. Lastly, TLRs, which can be found on the surface of many epithelial cells, provide specific immunity against pathogen-associated molecular patterns (PAMPs).

PAMPs are typically unique to individual microbes. 10, 27, 28 As previously mentioned, should any of the potential invaders traverse through the epithelium, leukocytes, act the first line of defense after the epithelium.

Besides mechanical, chemical, and microbiologic barriers, innate immunity plays a crucial role in providing protection against pathogens. Neutrophils and macrophages are an integral component of innate immunity in the middle ear and help in killing otopathogens. 9 Other cells that function as part of the initial response to infection or to foreign bodies within the middle ear include fibroblasts, mast cells, and NK cells. 9 Overall, the innate immune system is responsible for generating the initial protective responses by triggering TLRs leading to the production of cytokines in response to invasion of the middle ear by pathogens. [29] [30] [31] The up-regulation of these cytokines can result in multiple outcomes including eradication of the infection, or can also lead to chronic otitis media (COM), which is often seen in organisms such as Pseudomonas aeruginosa and Staphylococcus aureus. 32, 33 Such organisms create biofilms, which paradoxically increase host inflammation and cytokine production that can result in COM. 34 Specific cytokines that have been associated with COM include IL-8, TNF, IL-1 , IL-6, and IFN-. 35, 36 The inflammatory response is beneficial to a defending host because it up-regulates lymph flow, and this transports increasing quantities of antigen to the lymphoid tissue. As the antigen is transported to lymphoid tissue, it can be taken by dendritic cells that can activate adaptive immune responses.

The activation of adaptive immune responses facilitates in clearance of pathogens from the middle ear. 37 The nasopharyngeal tonsils and adenoids play an important inductive role as components of the mucosa-associated lymphoid tissue (MALT). These areas display similarities with lymph nodes because of their role in activating an adaptive response. An important implication of these adaptive immune system sites is that they can affect both the systemic and mucosal realms of adaptive immunity, making them a particularly versatile and specific defensive barrier for invasion against incoming viruses and bacteria.

The primary defensive mechanism of mucosal secretions is the immunoglobulin IgA. 38 IgA has demonstrated efficacy in protec- 

Besides immunologic responses, the ear has additional protection mechanisms against microbial colonization such as defensins and other biomolecules. Commensal organisms can also provide protection against ear infections. It has been observed that although some commensal organisms, which function to preserve the synchronous organism, can perpetuate OM, others may even be protective against contracting post-upper respiratory tract infection (URTI) OM. 48 

It is estimated that 94% of AOM cases are preceded by either the "common cold" or another URTI. 54 

Although cytokine production is often explained as a directed action by a 

Damage to the host mucociliary transport system of the middle ear is thought to be the initial event that facilitates evasion of Eustachian tube defenses by otopathogens. Mucus is the first barrier that protects the epithelium from viruses and bacteria. Secreted by goblet cells within the middle ear epithelium, mucins form a mucus layer that saturates the cilia and enable the mucociliary transportation clearance system of Eustachian tube (Fig. 1C) . The production of mucins is normally has been found to be the most common mucin involved in COM. 63 OM with effusion has demonstrated the presence of mucin 2 (MUC2), mucin 5AC (MUC5AC), and mucin 5B (MUC5B). 64 When left untreated, AOM may progress to chronic OM with effusion (COME). Specifically, NTHi is a common bacterial pathogen that contributes to this pathology. Although researchers continue to investigate NTHi's pathogenic mechanism, it is known that NTHi activates MUC5AC mucin transcription once the bacterial cell has been disturbed. 65 The initial step required to stimulate MUC5AC transcription is the triggering of p38 mitogen-activated protein kinase. Conversely, a negative feedback mechanism exists in which phosphoinositide 3-kinase-Akt pathway leads to inactivation of NTHi-influenced MUC5AC transcription by communicating with p38 mitogen-activated protein kinase pathway. 65 Ultimately, the activation of this pathway can lead to an overabundance of mucin, thereby contributing to conductive hearing loss in COME, decreased mucociliary clearance, increasing the bacterial retention in the middle ear and persistent infection. 65 Further, it has recently been discovered that curcumin, the principal curcuminoid of turmeric (Curcuma longa), is an inhibitor of NTHi-associated MUC5AC production. 66 

Besides mucin, many bacterial pathogens are also able to use phase variation to regulate gene expression and evade potent host immune responses (Fig. 2) , though researchers are still attempting to better elucidate this phenomenon. 52 demonstrated that animals with the "on" modA2 phaseversion had a higher burden of disease. [51] [52] [53] Tetranucleotide repeats that influence phase variation in lipo-oligosaccharide genes have also been studied. It was observed that an "on" to "off" switch of the oafA gene can provide an overall benefit in the middle ear. 71 NTHi is also known for hia transcription in its promotor region, and Hia protein, which is another form of phase variation. 70 As previously alluded to, hia is able to modify its poly-T tract. The overall objective of poly-T tract variation is to escape opsonophagocytic killing by the host immune system. It has been demonstrated that strains of NTHi with less hia expression are more successful at evasion of the host. 70 Phase variation also allows species of pathogens to manipulate their genetic makeup to obtain nutrients from their environment as well as to resist oxidative stress from host immune system. 52 Phase variation affects biofilm formation and can prolong its formation for a longer period of time leading to immune system evasion. 52 Simple sequence repeat (n+/-1)

The presence of simple sequence repeats (SSR) in outer membrane proteins of otopathogens leads to simple strand mispairing during genome replication. This causes alteration in DNA sequence and consequently "OFF/ON" expression of selected proteins. Due to unavailability of selected protein during "OFF" expression, antibody against the target is not able to recognize it leading to evasion of potent immune responses. B) Otopathogens can employ phasevariome genome variation leading to alteration of multiple genes and proteins. Antibodies are no longer able to recognize or bind with very low affinity to altered proteins leading to subversion of host immune responses Protection against oxidative stress is also seen in other OM pathogens, such as S. pneumoniae by manipulation of the thiol-specific antioxidant (TlpA/TSA), which is an additional example of host immune evasion. 73 Such phase variation can also be seen amongst other OM pathogens such as M. cararrhalis. 74 74, 76, 81, 82 In human experimental models with tympanostomy tube placement, there was increased expression of NanA, HylA, and PspA in transparent T variants. T variants also had increased levels of NanA and HylA at baseline, suggesting increased virulence in these variants. 77 These findings suggest that the T variant of the pneumococcal pathogen is responsible for the pathogenesis of OM. 81

In addition to phase variation, otopathogens take advantage of other existing infections to induce OM. This phenomenon typically involves viral coinfections and often makes OM a polymicrobial disease. 56 The most common viruses associated with OM are influenza virus, parainfluenza virus, rhinovirus, coronavirus, and RSV. 55, 56 Most frequently, OM occurs 2-5 day after a viral URI. 83 This coinfection results in poor antibiotic response, which is hypothesized to be due to reduced penetration of the middle ear in virus-infected children. 60 An additional theory is that the inflammatory mediators released by viruses result in delayed resolution of OM. 58 Animal models have shown that polymicrobial infection additionally results in hypersecretion and increased viscosity of mucus. 56 Similar findings have been seen among humans with influenza A infections. However, in humans, the biochemical quality of the secretions is modified as opposed to changes that occur simply in the quantity or viscosity of mucus. 84 Changes in secretions in human mucosa are thought to be due to viral neuraminidase. 85 Such polymicrobial interactions increase the virulence of pathogens while evading the host responses.

Biofilms provide an additional immunologic evasion mechanism.

Beyond increasing bacterial adherence and pathogenicity, biofilms have been found to be integral in the pathogenesis of OM. [86] [87] [88] [89] Biofilms have been demonstrated to contribute to the inability of the host immune system to clear bacteria during COM. 90 RNA also plays an important role in the initial steps of biofilm synthesis, though its overall function is less important. 100 Overall, the biofilm synthesized by NTHi has been found to release extracellular DNA and a -glucan. 100 In addition to eDNA, the other genetic association related to biofilm formation in NTHi involves the activation of lipooligosaccharides (LOS), which are located on the surface of bacteria. Phosphorylcholine (PCho) is found on some LOS and it has been found that PCho+ aids in stabilizing NTHi biofilms in animal models. 101 NTHi pathogenicity can be further enhanced by mutations in luxS.

This influences the quorum signaling pathway and can result in the development as well as the establishment of biofilms. 102 Biofilms can be particularly pathogenic in the case of OM, as the infections are polymicrobial and can hence create synergistic reactions, increased growth of organisms, antimicrobial tolerance, increased virulence and persistence, as well as exaggerated levels of exopolysaccharide (EPS). 88, 100, [103] [104] [105] [106] [107] [108] [109] [110] Biofilms have been found to be associated with adenoid hypertrophy and middle ear effusion. 88 Syntrophy may also occur, which supports the idea that the growth of one product increases the growth of another, contributing to infections with elevated pathogenicity. 111 A specific example of this is a coinfection with NanA influenza and S. pneumoniae. NanA is required for adherence of influenza as well as for the interplay of pathogenicity between the two organisms. 110

Glycans are carbohydrate structures that are found on the surfaces of pathogen and host structures, and they are often involved in highly specific interactions. 112 Changes in the bacterial capsular structure often underlie bacterial evasion of the host immune response. In some cases, these structures are inhibitory against immune functions of the host. 122 Other mechanisms include bacteria that create surface glycosylation structures that mimic host glycans. In many cases this allows for subversion of host immune system recognition. This mechanism helps microbes avoid immune defenses such as macrophages recognition that, in particular, utilize glycan surfaces to recognize both gram-positive and gram-negative bacteria.

Capsular polysaccharides have also been observed to mimic glycan structures on host surfaces. 122 A common mechanism that is illustrative of this concept involves variations of the group A Streptococcus (GAS) capsule. Hyaluronan (HA) is expressed on the GAS capsule. It has been observed that HA interacts with CD44 on host cells and that high molecular weight HA leads to decreased phagocytosis by macrophages. By comparison, low molecular weight HA leads to increased macrophage uptake.

Some bacteria alter protein glycosylation patterns and avoid cleavage by host proteases. NTHi appears to use glycosylation to protect its surface-exposed high molecular weight adhesin 1 (HMW1A). 123, 124 This action serves to attach HMW1A to the bacterial surface along with protecting it from degradation by the host.

NTHi peptidoglycans and an associated outer membrane protein (OMP) P6, serve as a ligand for TLR2. 125 Likewise, LOS is a ligand for TLR2 and TLR4. As one might expect, polymorphisms associated with OMP P6 or LOS have been found to be associated with recurrent cases of OM. 126 Bacteria can modify host glycans using enzymes such as glycosyltransferases and glycosidases. 122 Of these enzymes, the most commonly studied are the neuraminidases. S. pneumoniae has been observed to produce at least 10 glycosidases, 3 of which are neuraminidases that are integral in nutrient acquisition and pathogenesis, for example, N-acetylneuraminate lyase (NanA), sialidase B (NanB), and neuramidase C (NanC). 113 S. pneumoniae uses these enzymes for critical aspects of colonization such as utilizing carbon sources on host mucosal surfaces and in generating biofilm architecture. S. pneumoniae has been associated with induction of infection secondary to influenza A. The influenza A neuraminidase activity on sialylated structures appears to facilitate the S. pneumoniae secondary infection. 110 The methods by which glycans can be modified to evade the host immune system are diverse. Such mechanisms include the use of host carbohydrate structures as sources of carbon, targeting host glycans with pathogen toxins, using polysaccharides as sites of attachment or as an opportunity for mimicry of host structures. 122 As molecular mimicry via glycan modification can impact either innate or adaptive immune function, investigation of these interactions could pave the way for the development of future therapies.

OM pathogens are also able to escape host defenses by manipulating the host's innate immune system. Neutrophils are typically the first responders and form neutrophil extracellular traps (NETs) to kill pathogens. In AOM, animal models demonstrated that NETs and fibrin formation are initial host defenses in middle ear infections. [131] [132] [133] However, a persistence of NETs and fibrin contribute to biofilm formation, and hence chronic disease and effusion. 131 This can be attributed to the fact that NETs lead to a thicker effusion, which creates a more fertile ground for biofilm formation. 132 The end result is an association between NETs, COM and middle ear effusions. 133 Eosinophils in the middle ear are activated by cytokines such as IL-5 and eotaxin. Eventually, eosinophils undergo extracellular trap cell death, also known as ETosis. 140 ETosis involves cell death that results in the creation of extracellular traps (ETs), which play an important role in eosinophilic OM. 140 The mechanism by which these eosinophilic traps promote evasion of immunity by otopathogens is through an increased amount of eosinophilic secretions, resulting in increased viscosity. 128 This increased viscosity will hinder the clearance of otopathogens by the mucocilary system and will also prevent the penetration of antimicrobial compounds. Furthermore, the end product of ETosis is the expulsion of proteins, cytokines, chromatins, and lipid mediators, all of which are components of inflammation, perpetuating damage of surrounding tissue. 129 143, 144 It has also been demonstrated that otopathogenic P. aeruginosa enters and multiplies inside human and mouse primary macrophages that is dependent on both microtubule and actin dependent processes. 145 The colonization of macrophages by otopathogenic P. aeruginosa will lead to evasion of potent immune responses and may contribute to persistence of infection observed during CSOM.

COM/CSOM is also associated with increased biofilm formation, which further explains why COM infections are so difficult to treat. 146 However, it remains to be seen how COM pathogens such as P.

aeruginosa and S. aureus manipulates host immunity to promote biofilm formation in the middle ear leading to subversion of immune responses and induced infection. 

We are thankful to Dr. Valerie Gramling for critical reading of the manuscript.

J.M.P. and M.S. contributed equally to this work. All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.

The authors declare no conflicts of interest.

The diagnosis and management of acute otitis media

Population structure in nontypeable Haemophilus influenzae

Acute otitis media-diagnosis and treatment in the era of antibiotic resistant organisms: updated clinical practice guidelines

Microbiology of otitis media: a moving target

Nasopharyngeal reservoir of bacterial otitis media and sinusitis pathogens in adults during wellness and viral respiratory illness

Nontypeable Haemophilus influenzae (NTHi)

Tumor suppressor CYLD acts as a negative regulator for non-typeable Haemophilus influenzainduced inflammation in the middle ear and lung of mice

Surfactant in the middle ear and eustachian tube: a review

Role of innate immunity in the pathogenesis of otitis media

Otitis media

Defensin participation in innate and adaptive immunity

Towards the Application of Human Defensins as Antivirals

Antiviral mechanisms of human defensins

Peptides selected for binding to a virulent strain of Haemophilus influenzae by phage display are bactericidal

Expression of betadefensins in the tubotympanum of experimental otitis media

Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae

Innate immunity and the role of defensins in otitis media

Synergistic effect of interleukin 1 alpha on nontypeable Haemophilus influenzae-induced up-regulation of human beta-defensin 2 in middle ear epithelial cells

Activation of a Src-dependent Raf-MEK1/2-ERK signaling pathway is required for IL-1alpha-induced upregulation of beta-defensin 2 in human middle ear epithelial cells

Extracellular DNA within a nontypeable Haemophilus influenzae-induced biofilm binds human beta defensin-3 and reduces its antimicrobial activity

The multifunctional host defense peptide SPLUNC1 is critical for homeostasis of the mammalian upper airway

Functional roles of SPLUNC1 in the innate immune response against Gram-negative bacteria

PLUNC is a novel airway surfactant protein with anti-biofilm activity

Increased susceptibility to pulmonary Pseudomonas infection in Splunc1 knockout mice

NTHi induction of Cxcl2 and middle ear mucosal metaplasia in mice

Innate immunity in the respiratory epithelium

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

Recognition of bacterial infection by innate immune sensors

Correlative mRNA and protein expression of middle and inner ear inflammatory cytokines during mouse acute otitis media

Innate signaling in otitis media: pathogenesis and recovery

Panel 5: microbiology and immunology panel

Innate Immunity: orchestrating inflammation and resolution of otitis media

Chronic suppurative otitis media

Current concepts in the pathogenesis and treatment of chronic suppurative otitis media

Attenuated TLRs in middle ear mucosa contributes to susceptibility of chronic suppurative otitis media

Sinus aspirates in chronic rhinosinusitis: fungal colonization of paranasal sinuses, evaluation of ICAM-1 and IL-8 and studying of immunological effect of long-term macrolide therapy

Chapter 101 -Middle Ear and Eustachian Tube Mucosal Immunology

Inhibition of bacterial adherence by nasopharyngeal secretions

The potential of CD4 T-cell memory

Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens

Booster vaccinations: can immunologic memory outpace disease pathogenesis?

The expanding universe of T-cell subsets: Th1, Th2 and more

Cellular immune response in young children accounts for recurrent acute otitis media

CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens

T cell memory response to pneumococcal protein antigens in an area of high pneumococcal carriage and disease

Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children

Reduced serum IgG responses to pneumococcal antigens in otitis-prone children may be due to poor memory B-cell generation

Nasopharyngeal microbiota in infants and changes during viral upper respiratory tract infection and acute otitis media

Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species-and cell type-dependent manner

Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae

A biphasic epigenetic switch controls immunoevasion, virulence and niche adaptation in nontypeable Haemophilus influenzae

ModA2 phasevarion switching in nontypeable Haemophilus influenzae increases the severity of experimental otitis media

Epigenetic regulation alters biofilm architecture and composition in multiple clinical isolates of nontypeable Haemophilus influenzae

Importance of viruses in acute otitis media

Viral upper respiratory tract infection and otitis media complication in young children

Immunopathogenesis of polymicrobial otitis media

Effect of Streptococcus pneumoniae and influenza A virus on middle ear antimicrobial pharmacokinetics in experimental otitis media

Role of leukotriene B4 and interleukin-8 in acute bacterial and viral otitis media

Virus and bacteria enhance histamine production in middle ear fluids of children with acute otitis media

Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media

The immunoregulatory and allergy-associated cytokines in the aetiology of the otitis media with effusion

Otitis media and nasopharyngeal colonization in CCL3(-/-) Mice

MUC5B Is the predominant mucin glycoprotein in chronic otitis media fluid

Association of gel-forming mucins and aquaporin gene expression with hearing loss, effusion viscosity, and inflammation in otitis media with effusion

Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphoinositide 3-kinase-Akt pathway

Curcumin inhibits NTHiinduced MUC5AC mucin overproduction in otitis media via upregulation of MAPK phosphatase MKP-1

Nontypeable Haemophilus influenzae lipooligosaccharide expresses a terminal ketodeoxyoctanoate in vivo, which can be used as a target for bactericidal antibody. mBio

Influenza A virus alters pneumococcal nasal colonization and middle ear infection independently of phase variation

Frequencies of lipopolysaccharide-defined epitopes in Haemophilus influenzae type b and non-typable isolates determined with monoclonal antibodies

Selection and counterselection of hia expression reveals a key role for phase-variable expression of Hia in infection caused by nontypeable Haemophilus influenzae

Selection for phase variation of LOS biosynthetic genes frequently occurs in progression of nontypeable Haemophilus influenzae infection from the nasopharynx to the middle ear of human patients

The ModA2 phasevarion of nontypeable Haemophilus influenzae regulates resistance to oxidative stress and killing by human neutrophils

Pneumococcal gene complex involved in resistance to extracellular oxidative stress

Role of the alternative and classical complement activation pathway in complement mediated killing against Streptococcus pneumoniae colony opacity variants during acute pneumococcal otitis media in mice

ModM DNA methyltransferase methylome analysis reveals a potential role for Moraxella catarrhalis phasevarions in otitis media

Streptococcus pneumoniae isolates from middle ear fluid and nasopharynx of children with acute otitis media exhibit phase variation

Interaction of pneumococcal phase variation, host and pressure/gas composition: virulence expression of NanA, HylA, PspA and CbpA in simulated otitis media

Characterization of in vitro biofilm-associated pneumococcal phase variants of a clinically relevant serotype 3 clone

Differential expression of cytokine genes and inducible nitric oxide synthase induced by opacity phenotype variants of Streptococcus pneumoniae during acute otitis media in the rat

Effect of influenza A virus infection on nasopharyngeal colonization and otitis media induced by transparent or opaque phenotype variants of Streptococcus pneumoniae in the chinchilla model

Interaction of phase variation, host and pressure/gas composition: pneumococcal gene expression of PsaA, SpxB, Ply and LytA in simulated middle ear environments

Interaction of pneumococcal phase variation and middle ear pressure/gas composition: an in vitro model of simulated otitis media

The microbiology of otitis media

Pattern of nasal secretions during experimental influenza virus infection

Effects of influenza A virus on lectin-binding patterns in murine nasopharyngeal mucosa and on bacterial colonization

Biofilms: microbial life on surfaces

relation between food concentration and surface for bacterial growth

Role of bacterial biofilm in development of middle ear effusion

Haemophilus influenzae biofilm formation in chronic otitis media with effusion

Haemophilus parainfluenzae strain ATCC 33392 forms biofilms in vitro and during experimental otitis media infections

Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae

Haemophilus influenzae and Streptococcus pneumoniae: living together in a biofilm

Role of Streptococcus pneumoniae proteins in evasion of complement-mediated immunity

Extracellular DNA and type IV pilus expression regulate the structure and linetics of biofilm formation by montypeable Haemophilus influenzae

Nontypeable Haemophilus influenzae releases DNA and DNABII proteins via a T4SS-like complex and ComE of the type IV pilus machinery

A novel streptococcal cellcell communication peptide promotes pneumococcal virulence and biofilm formation

Bacterial lysis through interference with peptidoglycan synthesis increases biofilm formation by nontypeable Haemophilus influenzae

The DNABII family of proteins is comprised of the only nucleoid associated proteins required for nontypeable Haemophilus influenzae biofilm structure. Microbiologyopen

Identification of biofilms in post-tympanostomy tube otorrhea

Evidence of the presence of nucleic acids and beta-glucan in the matrix of non-typeable Haemophilus influenzae in vitro biofilms

Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media

LuxS promotes biofilm maturation and persistence of nontypeable Haemophilus influenzae in vivo via modulation of lipooligosaccharides on the bacterial surface

Gram negative species associated with active destructive periodontal lesions

Bacterial and host interactions of oral streptococci

Bacteriology of severe periodontitis in young adult humans

Bacteriology of human experimental gingivitis: effect of plaque age

Interspecies communication in Streptococcus gordonii-Veillonella atypica biofilms: signaling in flow conditions requires juxtaposition

Population-based study of salivary carriage of periodontal pathogens in adults

In vitro multi-species biofilms of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa and their host interaction during in vivo colonization of an otitis media rat model

Pneumococcal neuraminidase A (NanA) promotes biofilm formation and synergizes with influenza A virus in nasal colonization and middle ear infection

Metabolite cross-feeding enhances virulence in a model polymicrobial infection

Bacterial glycans: key mediators of diverse host immune responses

Pneumococcal modification of host sugars: a major contributor to colonization of the human airway?

Host adaptation of a bacterial toxin from the human pathogen Salmonella Typhi

The cholesteroldependent cytolysins pneumolysin and streptolysin O require binding to red blood cell glycans for hemolytic activity

Blood group antigen recognition via the group A streptococcal M protein mediates host colonization

The lacdiNAc-specific adhesin LabA mediates adhesion of Helicobacter pylori to human gastric mucosa

Diversity of microbial sialic acid metabolism

Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media

Novel sialic acid transporter of Haemophilus influenzae

Host sialic acids: a delicacy for the pathogen with discerning taste

Glycointeractions in bacterial pathogenesis

The Haemophilus influenzae HMW1 adhesin is glycosylated in a process that requires HMW1C and phosphoglucomutase, an enzyme involved in lipooligosaccharide biosynthesis

The Haemophilus influenzae HMW1 adhesin is a glycoprotein with an unusual N-linked carbohydrate modification

Nontypeable Haemophilus influenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKK -I B -NF-B signaling pathways

Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media

Attenuated TLRs in middle ear mucosa contributes to susceptibility of chronic suppurative otitis media

Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans

Epidemic meningitis, meningococcaemia, and Neisseria meningitidis

A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies

Neutrophil extracellular traps and fibrin in otitis media: analysis of human and chinchilla temporal bones

Neutrophil extracellular traps and bacterial biofilms in middle ear effusion of children with recurrent acute otitis media-a potential treatment target

Proteomic characterization of middle ear fluid confirms neutrophil extracellular traps as a predominant innate immune response in chronic otitis media

Evasion of neutrophil extracellular traps by respiratory pathogens

Antibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media

Neutrophil extracellular traps in pulmonary diseases: too much of a good thing

Neutrophil extracellular traps in respiratory disease: guided anti-microbial traps or toxic webs? Paediatr Respir Rev

Eosinophil extracellular trap cell death-derived DNA traps: Their presence in secretions and functional attributes

Eosinophil ETosis and DNA traps: a new look at eosinophilic inflammation

Eosinophilic otitis media: the aftermath of eosinophil extracellular trap cell death

Evidence of eosinophil, neutrophil, and mast-cell mediators in the effusion of OME patients with and without atopy

Pseudomonas aeruginosa Activates PKC-Alpha to invade middle ear epithelial cells

The protein kinase C (PKC) family of proteins in cytokine signaling in hematopoiesis

Recurrent otorrhea in chronic suppurative otitis media: is biofilm the missing link?

Otopathogenic Pseudomonas aeruginosa enters and survives inside macrophages

The genetics of cholesteatoma. A systematic review using narrative synthesis

Antibodies against the majority subunit of type IV pili disperse nontypeable Haemophilus influenzae biofilms in a LuxS-dependent manner and confer therapeutic resolution of experimental otitis media

Understanding the aetiology and resolution of chronic otitis media from animal and human studies

Subversion of host immune responses by otopathogens during otitis media